irinotecan has been researched along with quinoxalines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Grant, SC; Kris, MG; Miller, VA; Pisters, KM; Rigas, JR | 1 |
Chen, L; Chen, Y; Deng, D; Guo, Y; He, W; Liu, K; Peng, B; Si, W; Tang, M; Xiang, M; Xu, D; Xu, Q; Yang, T; Yang, Y; Yuan, X; Zhang, C; Zhang, S; Zou, Y | 1 |
1 review(s) available for irinotecan and quinoxalines
Article | Year |
---|---|
New chemotherapeutic agents for non-small cell lung cancer.
Topics: Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Paclitaxel; Quinoxalines; Sulfanilamides; Taxoids; Topotecan; Vinblastine; Vinorelbine | 1995 |
1 other study(ies) available for irinotecan and quinoxalines
Article | Year |
---|---|
Discovery and Evaluation of 3-Quinoxalin Urea Derivatives as Potent, Selective, and Orally Available ATM Inhibitors Combined with Chemotherapy for the Treatment of Cancer via Goal-Oriented Molecule Generation and Virtual Screening.
Topics: Ataxia Telangiectasia Mutated Proteins; Early Detection of Cancer; Goals; Humans; Irinotecan; Neoplasms; Quinoxalines | 2023 |